Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Revenue: 2020-2024

Historic Revenue for Prime Medicine (PRME) over the last 2 years, with Dec 2024 value amounting to $3.0 million.

  • Prime Medicine's Revenue rose 486.12% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is N/A change from last year.
  • As of FY2024, Prime Medicine's Revenue stood at $3.0 million, which was down 42.74% from $5.2 million recorded in FY2020.
  • Prime Medicine's Revenue's 5-year high stood at $5.2 million during FY2020, with a 5-year trough of $3.0 million in FY2024.
  • Its 1-year average for Revenue is $3.0 million, with a median of $3.0 million in 2024.